跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
SFDA
/
PRISTIQ 50MG EXTENDED RELEASE TABLETS
Authorized
NCE
PRISTIQ 50MG EXTENDED RELEASE TABLETS
Unknown
🇸🇦 Saudi Food and Drug Authority
Approval Date
N/A
Approval ID
68ca677263bfc805
Company
Unknown
Type
NCE
Approval Details
Approval Id
68ca677263bfc805
Drug Approval Sfda Name
PRISTIQ 50MG EXTENDED RELEASE TABLETS
Trade Name
PRISTIQ 50MG EXTENDED RELEASE TABLETS
Generic Name
DESVENLAFAXINE SUCCINATE
Register Number
2904257311
Register Year
2010
Drug Type
NCE
Route Of Administration
Oral use
Package Type
Bottle
Package Size
30
Legal Status
Prescription
Authorization Status
Valid
Marketing Status
Marketed
Product Control
Uncontrolled
Storage Conditions
store below 30°c
Shelf Life
36 Months
Distribution Site
Pharmacy
Description Code
7000000368-50-100000073683
Price
78.5
Active Ingredients
Authorized
Quick Info
Agency
SFDA
Country
🇸🇦
Approval ID
68ca677263bfc805
Type
NCE
Back to SFDA Approvals
PRISTIQ 50MG EXTENDED RELEASE TABLETS - SFDA Drug Approval Details